Geographic Variation in Diagnostic Performance of Amsel Criteria and Nugent Score for Vaginal Dysbiosis Defined by 16S rRNA Gene Sequencing

Meilin Zhu, Andile Mtshali, Gugulethu Mzobe, Nzuzo Magini, Laura Symul and , E.A.
Additional contact information
Laura Symul: Université catholique de Louvain, LIDAM/ISBA, Belgium

No 2026031, LIDAM Reprints ISBA from Université catholique de Louvain, Institute of Statistics, Biostatistics and Actuarial Sciences (ISBA)

Abstract: Background : Vaginal dysbiosis characterized by low abundance of vaginal lactobacilli and increased bacterial community diversity, is implicated in multiple adverse health outcomes and is an emerging target for preventive interventions, including live biotherapeutic products. The most common clinical presentation of vaginal dysbiosis is bacterial vaginosis (BV), but at least half of people are asymptomatic. Methods : We compared identification of BV by Nugent score and Amsel criteria for screening specimens from a Phase 1b randomized trial of a live biotherapeutic product conducted at 2 sites (CAPRISA, South Africa; MGH, USA), as well as a single follow-up visit from enrolled participants. Using 16S rRNA gene sequencing-based categorization of community state type (CST) as the reference and multinomial mixed-effects logistic models, we evaluated the association of Amsel BV and Nugent BV with CST IV (including subtypes IV-A and IV-B) and tested for site-specific effects. Results : Amsel BV was significantly associated with CST IV-A and IV-B; however, the strength of association was significantly diminished at CAPRISA compared with MGH, pointing to site-specific assessment differences or underlying biological variation. Nugent BV yielded stronger associations with CST IV-A, and IV-B and showed no evidence of a site-specific interaction, indicating consistent performance across sites. Conclusions : These findings indicate that diagnostic performance for vaginal dysbiosis varies by framework: Amsel criteria are more susceptible to geographical site effects, whereas Nugent score demonstrates stronger and more site-agnostic associations. For clinical studies targeting vaginal dysbiosis, Nugent scoring and/or sequencing-based approaches should be prioritized for vaginal dysbiosis endpoint definition and stratification.

Keywords: Bacterial vaginosis; vaginal dysbiosis; Nugent score; Amsel criteria; vaginal microbiome (search for similar items in EconPapers)
Pages: 11
Date: 2026-08-11
Note: In: The Journal of Infectious Diseases, 2026, jiag399
References: Add references at CitEc
Citations:

Downloads: (external link)
https://research.dial.uclouvain.be/

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aiz:louvar:2026031

DOI: 10.1093/infdis/jiag399

Access Statistics for this paper

More papers in LIDAM Reprints ISBA from Université catholique de Louvain, Institute of Statistics, Biostatistics and Actuarial Sciences (ISBA) Voie du Roman Pays 20, 1348 Louvain-la-Neuve (Belgium). Contact information at EDIRC.
Bibliographic data for series maintained by Alain Gillis ().